In the ever-evolving landscape of toxicology and exposure science, comprehending the pathways through which chemicals enter the human body remains a cornerstone of safeguarding public health. One such exposure route, dermal absorption, plays a pivotal role especially in pharmaceutical development, occupational safety, and environmental health. Despite its significance, capturing detailed toxicokinetic (TK) data through in vivo studies presents formidable challenges, often limited by ethical, financial, and logistical constraints. Enter the innovative approach spearheaded by Meade, Schacht, Evans, and their colleagues, who have forged a new methodological pathway for integrating dermal absorption into high-throughput toxicokinetic modeling—promising a transformative leap in how we assess chemical risks in real-world contexts.
Dermal absorption embodies a complex interplay between a chemical’s physicochemical properties and the skin’s intricate biological barriers. The skin, our body’s largest organ, serves as a dynamic interface with the environment. It is equipped with multiple layers that variably regulate permeation, including the stratum corneum, epidermis, and dermis, each with distinct roles and permeability characteristics. Historically, the unpredictability and variability inherent in these layers have hindered the establishment of rapid, accurate models predicting how chemicals migrate through skin and into systemic circulation. Traditional in vivo TK studies, although informative, are resource-intensive and cannot practically encompass the thousands of existing industrial and consumer chemicals lacking thorough toxicity datasets.
The researchers’ endeavor revolves around harnessing existing in vitro bioactivity data to inform and catalyze the development of computational frameworks that can simulate dermal absorption mechanisms at scale. This strategy is particularly valuable given that regulatory agencies increasingly demand safety evaluations for myriad substances whose in vivo data are sparse or entirely absent. The utilization of high-throughput analytical techniques, coupled with mechanistic insights, enables the extrapolation of dermal penetration potential without necessitating direct human or animal testing, paving the way for ethical and timely risk assessments.
A core innovation presented lies in the integration of dermal absorption parameters into physiologically based toxicokinetic (PBTK) models that traditionally prioritize inhalation and oral exposure pathways. By incorporating dermal absorption coefficients derived from in vitro assays—such as skin permeation studies using human or animal tissue equivalents—the model achieves a more holistic representation of chemical disposition within the body. Importantly, this approach bridges the critical gap between in vitro bioactivity profiles and real-world exposure scenarios, enabling refined predictions of internal dose metrics that drive toxicological outcomes.
The modeling framework accounts for several key determinants of dermal uptake. These include the partitioning behavior of chemicals between the stratum corneum and underlying tissues, diffusion kinetics, and metabolic transformations that can occur within skin layers. Additionally, the model incorporates interindividual variability parameters, addressing differences in skin thickness, hydration state, and potential pre-existing skin conditions that modulate permeability. Such sophistication is essential for realistically projecting exposure risks, especially in sensitive populations or occupational settings with repeated dermal contact.
Crucially, the researchers emphasize that their high-throughput dermal absorption framework is designed to seamlessly integrate with existing large-scale toxicology platforms, such as the Tox21 and ToxCast programs, which generate copious amounts of in vitro bioactivity data. By linking these datasets with TK modeling, the framework operationalizes a pipeline from molecular activity to systemic exposure—fulfilling a vital need in risk assessment workflows. This capability also supports chemical prioritization efforts, enabling regulators and industry stakeholders to allocate resources toward substances posing the greatest systemic risks.
The implications of this work resonate profoundly within the environmental health domain. Chemical contaminants prevalent in soils, water, and air can contact skin directly, constituting a significant exposure route, particularly in vulnerable communities near industrial sites. Accurately modeling dermal absorption potentially transforms environmental risk assessments, influencing remediation priorities and public health interventions. Furthermore, the pharmaceutical industry benefits by better characterizing percutaneous drug delivery and potential systemic side effects, streamlining drug development and safety evaluations.
Beyond facilitating chemical safety decisions, the framework holds promise for advancing personalized medicine. By incorporating individual-specific factors such as genetic polymorphisms affecting skin metabolism and barrier function, future iterations could tailor exposure predictions to individuals, enhancing precision risk assessments. This personalization could unveil subtle differential susceptibilities concealed within population-averaged models, addressing long-standing disparities in chemical exposure outcomes.
To validate their model, Meade and colleagues undertook comparisons between predicted absorption metrics and empirical data from established dermal penetration studies. Their results illustrated strong concordance, attesting to the model’s robustness and reliability. This validation underpins their confidence that the model can serve as a surrogate for resource-demanding experimental procedures, accelerating safety assessments while maintaining scientific rigor.
Looking ahead, the authors propose iterative refinement using machine learning algorithms fed by expanding bioactivity and exposure datasets. This dynamic evolution promises to enhance predictive accuracy, identify previously unrecognized factors influencing absorption, and adapt to novel chemical structures and formulations. Such adaptability is crucial in an era of rapid chemical innovation, where traditional toxicological testing lags behind the pace of market introduction.
The adoption of this groundbreaking framework could also stimulate regulatory evolution by furnishing agencies with quantitative tools that harmonize exposure assessment across multiple routes. Including dermal absorption data in quantitative risk models can reshape permissible exposure limits and occupational safety guidelines, providing stronger protective measures for workers and consumers alike. Stakeholders may hence anticipate revamped chemical management policies rooted in sound, mechanistically informed TK principles.
In sum, the integration of a dermal absorption component into high-throughput toxicokinetic modeling heralds a new chapter in exposure science, one marked by enhanced predictive capability, ethical alignment, and systemic perspective. By bridging laboratory bioactivity assays with computational physiology, this approach empowers toxicologists, regulators, and health professionals to navigate complex exposure landscapes more effectively, informing decisions that safeguard human health amidst chemical complexity.
This innovation underscores the vital role of interdisciplinary collaboration, leveraging bioengineering, computational sciences, and toxicology to confront longstanding challenges in chemical risk assessment. It exemplifies how advancing scientific methodologies can transform fundamental understanding and practical application, ultimately contributing to a safer and healthier society. As the chemical universe continues to expand, tools such as these will be indispensable in charting the pathways from exposure to effect, identifying hazards before harm occurs.
In conclusion, the work by Meade et al. presents a visionary approach that strategically addresses significant gaps in dermal toxicokinetics by harnessing existing data streams within a robust modeling infrastructure. Their contribution supports a paradigm shift towards non-animal, rapid, and integrative chemical safety evaluations that align with contemporary ethical standards and regulatory demands. The future of dermal absorption assessment is poised for transformation, promising enhanced protection and informed stewardship of chemical exposures worldwide.
Subject of Research: Dermal absorption in toxicokinetic modeling and high-throughput exposure assessment.
Article Title: Incorporating a dermal absorption route into high throughput toxicokinetic modeling.
Article References:
Meade, A., Schacht, C.M., Evans, M.V. et al. Incorporating a dermal absorption route into high throughput toxicokinetic modeling. J Expo Sci Environ Epidemiol (2026). https://doi.org/10.1038/s41370-026-00881-8
Image Credits: AI Generated
DOI: 10.1038/s41370-026-00881-8
Tags: challenges in dermal toxicokinetic datachemical skin permeation modelingdermal absorption toxicokinetic modelingdermal exposure risk assessmentenvironmental health dermal toxicokineticshigh-throughput toxicokinetic methodsin vivo vs in silico toxicokinetic studiesintegrating dermal absorption in chemical risk modelsoccupational chemical exposure dermal riskspharmaceutical dermal absorption modelingphysicochemical properties and skin absorptionskin barrier permeability in toxicology
